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ABSTRACT Fo¨rster resonance energy transfer (FRET)-based biosensors for the quantitative analysis of intracellular sig-
naling, including sensors for monitoring cyclic adenosine monophosphate (cAMP), are of increasing interest. The measurement
of the donor/acceptor emission ratio in tandem biosensors excited at the donor excitation wavelength is a commonly used
technique. A general problem, however, is that this ratio varies not only with the changes in cAMP concentration but also with
the changes of the ionic environment or other factors affecting the folding probability of the ﬂuorophores. Here, we use a spec-
tral FRET analysis on the basis of two excitation wavelengths to obtain a reliable measure of the absolute cAMP concentrations
with high temporal and spatial resolution by using an ‘‘exchange protein directly activated by cAMP’’. In this approach, FRET
analysis is simpliﬁed and does not require additional calibration routines. The change in FRET efﬁciency (E) of the biosensor
caused by [cAMP] changes was determined as DE ¼ 15%, whereas E varies between 35% at low and 20% at high [cAMP],
allowing quantitative measurement of cAMP concentration in the range from 150 nM to 15 mM. The method described is also
suitable for other FRET-based biosensors with a 1:1 donor/acceptor stoichiometry. As a proof of principle, we measured the
specially resolved cAMP concentration within living cells and determined the dynamic changes of cAMP levels after stimulation
of the Gs-coupled serotonin receptor subtype 7 (5-HT7).
INTRODUCTION
Fo¨rster resonance energy transfer (FRET)-based biosensors
are frequently used for the analysis of molecular processes
within living cells. However, using the ﬂuorescence emission
ratio in most cases allows only the analysis of qualitative
changes. One important reason for that is the dependence of
the emission properties of the donor and/or acceptor on their
ionic environment (1).
Cyclic adenosine monophosphate (cAMP) is a ubiquitous
second messenger that is regulated by G-protein coupled
receptors (GPCRs) targeting the enzyme adenylyl cyclase
(AC) to upregulate or downregulate the production of cAMP
(2,3). These processes can be monitored online, with the
‘‘exchange protein directly activated by cAMP’’ (Epac) (4).
Rich et al. (5) showed that cAMP signals differ spatially and
temporally within cells. They also observed a stimulus-
correlated rise of cAMP concentration that is limited to the
inner side of themembrane. This ﬁnding promoted the concept
of functional microdomains of cAMP production and action
(6), in which metabotropic receptors, G-proteins, membrane-
associated ACs, and cAMP targets are aggregated. The recent
ﬁnding of a family of cytosolic ACs (7), however, suggests
that cAMP may also act over long distances.
To analyze the spatiotemporal changes of cellular cAMP
levels, several ﬂuorescence biosensors of cAMP have been
created using Epac as a backbone (8–10). Epacs have either
one (Epac1) or two (Epac2) cAMP-binding domains, a gua-
nine nucleotide exchange motif (GEF) for small GTPases
Rap1 and Rap2, and a disheveled, EGL-10, pleckstrin do-
main, which determine their membrane localization (4).
These biosensors consist either of the full-length Epac1
protein or a single domain, which includes only the cAMP-
binding part of Epac1 or Epac2.
The function of such ﬂuorescence biosensors for cAMP is
based on FRET (11). Binding cAMP to the biosensor pro-
teins leads to a conformational change of the FRET pair and,
therefore, to a change in the FRET signal originating from a
complementary change of donor and acceptor emission. Thus,
the intensity ratio between donor and acceptor emission is
typically used for the evaluation of FRET. All available bio-
sensors suitable for quantitative cAMP measurements (8–10),
however, are labeled with enhanced cyan ﬂuorescence protein
(eCFP) and enhanced yellow ﬂuorescence protein (eYFP)
(12). It is necessary to note that the ﬂuorescence of eYFP is
highly sensitive to changes in pH and other ion concentrations
(e.g., [Cl]) (1), which may vary in an activity-dependent
manner (13–15). Therefore, physiological measurements of
cAMP must be affected by such changes.
Here, we demonstrated that the eYFP/eCFP intensity ratio
is not valid for quantitative cAMP measurements; it is only
useful for determining relative cAMP level changes. As a
solution, a simpliﬁed spectral FRET analysis method is pre-
sented to obtain a relative apparent FRET efﬁciency and to
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measure [cAMP] quantitatively. This method is applied to an
Epac1 sensor CFP-Epac(dDEP-CD)-YFP (in the following,
labeled ‘‘EPAC*’’) developed by Ponsioen et al. (10). In this
construct, the amino terminus of Epac1 is fused to eCFP,
whereas the carboxy terminus is fused to eYFP.The catalytical
property for Rap1 and themembrane-linking DEP domain are
deleted, resulting in a cytosolic localization of the sensor.
Binding cAMP to the Epac1 construct induces a conforma-
tional change of the protein, resulting in a distance and ori-
entation change of eCFP between eYFP. By using this sensor,
Ponsioen et al. have demonstrated that the reduction of intra-
cellular cAMP leads to an increase in energy transfer between
eCFP and eYFP, whereas it is diminished by a rise of cAMP.
Using this, to our knowledge, novel FRET analysis
method, we applied FRET-based cAMP biosensor to obtain
spatially resolved quantitative data on intracellular cAMP
concentration by measuring the donor and acceptor ﬂuores-
cence intensity signal at two excitation wavelengths. This
approach was demonstrated for the quantitative detection of
changes in [cAMP] in neuroblastoma cells expressing the
serotonin receptor subtype 7 (5-HT7), which is known to be
positively coupled to ACs.
MATERIALS AND METHODS
Plasmids
Cells were transfected with cDNA (complementary DNA) encoding for
the following proteins: 1), eCFP (pECFP-N1, Clontech Laboratories,
Mountain View, CA); 2), eYFP (pEYFP-N1, Clontech Laboratories); 3),
empty vector (pcDNA3.1/CAT, Invitrogen, Karlsruhe, Germany); 4), the
Epac1 construct eCFP-Epac(dDEP-CD)-eYFP in a pcDNA3 from Ponsioen
et al. (10) (EPAC*); or 5), a cotransfection of the myc-tagged 5-HT7-re-
ceptor cloned into the pcDNA3.1 plasmid (16) together with EPAC*.
Adherent cell culture and transfection
Mouse N1E-115 neuroblastoma cells from the American Type Culture col-
lection (LGC Promochem, Wesel, Germany) were grown in Dulbecco’s
modiﬁed Eagle’s medium (Sigma-Aldrich, Munich, Germany) containing
10% fetal calf serum and 1% penicillin/streptomycin at 37C under 5% CO2.
Twenty-four hours before transient transfection, cells were seeded at low
density (13 106 cells) either in 60 mm dishes (for ﬂuorescence spectroscopy
measurements) or in 10 mm dishes including glass coverslips on the bottom
(for microscopic measurements). Cells were transfected with appropriate
vectors using Lipofectamine2000 reagent (Invitrogen) according to the
manufacturer’s instruction. Three hours after transfection, cells were serum
starved overnight before analysis. Continuative incubation led to a con-
glomeration of the EPAC* proteins.
Fluorescence spectroscopy
Sample preparation
Exposure of the in vivo used EPAC* proteins to a given solution was achieved
by lysis of transfected N1E-115 cells. To remove phenol-red from the N1E-
115 cells, cells were washed three times with intracellular solution (140 mM
KCl, 5 mMNaCl, 1 mMMgCl2, and 10 mMHEPES at pH 7.2) and thereafter
suspended in 2.3 mL intracellular solution and homogenized with an S30
homogenizer (Schu¨tt Labortechnik, Goettingen, Germany) at 2500 rpm for
2 min. This homogenate was centrifuged for 1 min at 21,0003 g and at 4C.
Two milliliters of the supernatant was directly ﬁlled into quartz cuvettes
equipped with a magnetic stirrer.
Fluorescence spectrometer
Spectroscopic measurements were performed using a Fluorolog-322 (Horiba
Jobin Yvon, Munich, Germany) at 25C. Measurements were performed in
1 nm wavelength steps with 2 nm spectral resolution for excitation and
emission. Samples were placed in quartz cuvettes (10 3 10 mm2) and con-
tinuously mixed by a magnetic stirrer. To suppress scattering and re-
absorption, spectra were measured in a front face arrangement.
For the estimate of spectral contributions due to light scattering and au-
toﬂuorescence of the cells, reference spectra of transfected cellswith an empty
vectorwere recorded and considered an additional background component for
the ﬁtting procedure. Special care has been taken for scattering and reabsorp-
tion effects in respect to the cell lysate and the ﬂuorophore expression level.
Fluorescence reference spectra of eCFP
and eYFP
The cAMP-sensing EPAC* from Ponsioen et al. (10) is a biosensor based on
a FRET pair of the ﬂuorophores eCFP and eYFP. From a comprehensive
analysis of the emission properties of EPAC*, its ﬂuorescence spectrum was
found as a linear combination of the ﬂuorescence spectra of eCFP and eYFP
in the complete cAMP concentration range (0 M – 10 mM) and for a pH
range (pH 6.5–8). The reference emission spectra of eCFP and eYFP, FrefD ðlÞ
and FrefA ðlÞ; used for the unmixing procedure (see Fig. 2), were obtained at
420 nm excitation.
The ﬂuorescence excitation and emission spectra of eCFP and eYFP were
obtained separately. Thereby, the line shape of their emission spectrum did
not change when the excitation wavelength was varied. Typical normalized
spectra are shown in Fig. 1. The ﬂuorescence excitation spectra were taken at
500 nm and 550 nm emission for eCFP and eYFP, respectively.
Choice of excitation wavelengths and
emission channels
The optimal excitation wavelength for ﬂuorescence spectrometry and
emission channels in microscopic measurements have been determined from
FIGURE 1 Excitation (dashed line) and emission (solid line) spectra of
eCFP (blue) and eYFP (green) measured in a ﬂuorescence spectrometer.
Spectra were obtained by measuring a diluted supernatant of homogenized
and centrifuged N1E-115 cells transfected with eCFP and eYFP, respec-
tively. The ﬁlter set used in the microscope is represented by the ﬁlled areas:
excitation bandwidth for eCFP (violet) and for eYFP (green) as well as
emission bandwidth for eCFP (light blue) and for eYFP (light yellow).
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the ﬂuorescence excitation and emission spectra of individual ﬂuorescence
properties of eCFP and eYFP in the diluted supernatant of homogenized and
centrifuged N1E-115 cells that had been transfected with DNA for eCFP and
eYFP. In addition to the reference spectra, the transmission spectra of the
ﬁlter set used for microscopic measurements are shown in Fig. 1. The spectra
illustrate the strong overlap of the emission spectrum of eCFP with the ex-
citation spectrum of eYFP, which, on the one hand, is an essential condition
for FRET but, on the other hand, complicates data analysis, especially in ﬁlter
cube experiments. A donor excitation wavelength of 420/10 nm was chosen,
which is a compromise between the excitation maximum of eCFP at 430 nm
and the maximum of the eCFP/eYFP absorption ratio at;400 nm. Due to the
small Stokes shift of eYFP of ;20 nm, 500/10 nm was used as a second
excitation wavelength instead of 515 nm, where eYFP excitation reaches its
maximum. This allows the use of an emission bandpass ﬁlter, which includes
the eYFP emission maximum at ;525 nm and is well separated from ex-
citation. In addition, eCFP is not excited at 500 nm excitation, which is a
necessary condition for the derived formalism (see Data Analysis). Finally,
the donor emission bandpass ﬁlter was chosen to separate from acceptor
excitation and to detect as much eCFP signal as possible.
Fluorescence microscopy
Solution application
A coverslip with transfected N1E-115 cells was positioned underneath the
microscope objective into a bath chamber equipped with a solution inﬂow
and suction. Cells were kept in a solution of 150mMNaCl, 5 mMKCl, 2 mM
CaCl2, 1 mM MgCl2, 10 mM HEPES, and 10 mM natrium-D-glucose (pH
7.4). 5-HT7 agonist application was realized by exchanging the bath solution
with solution containing 1 mM 5-carboxamidotryptamine ((5-CT), Tocris
Bioscience, Bristol, UK).
Microscope
For microscopy, we used an upright epiﬂuorescence microscope equipped
with a water immersion objective (LUMFI, 403, NA 1.1, Hamburg,
Olympus, Germany). A 100 W xenon lamp attached to a monochromator
(Optoscan, Cairn Research, Faversham, UK) was used as an excitation light
source that was coupled to the microscope via ﬁber optics. A dichroic mirror
(455 nm) was taken to separate emission from excitation light. According to
its properties, the higher intensity of the second excitation wavelength was
much less reﬂected, and, thus, similar intensities were obtained at the two
excitation wavelengths, 420/10 nm and 500/10 nm. Using a DualView
(Optical Insights, Tucson, AZ), the ﬂuorescence emission signal was split by
a dichroic mirror (515 nm) into 470/30 nm for the eCFP channel and 535/30
nm for the eYFP channel. With an iXon camera DV887DCS (Andor
Technology, South Windsor, CT), three principal images were acquired: a)
the donor image at eCFP excitation and eCFP emission wavelength, b) the
FRET image at eCFP excitation and eYFP emission wavelength, and c) the
acceptor image at eYFP excitation and eYFP emission wavelength. Camera
gain and exposure times (;3 s) were chosen according to the ﬂuorescence
intensity of the cells and were equal for all image series of an experiment.
Special care was taken that bleaching was not signiﬁcant.
Determination of the eYFP extinction ratio (a)
and the eCFP ‘‘bleedthrough’’ (b)
The ratio of the eYFP extinction, a ¼ FAexlD ;emlA =F
A
exlA ;emlA
, was obtained
from the FRET and the eYFP images by measuring cells expressing only
eYFP. Special care was taken to use similar experimental conditions as in the
EPAC* experiments. For the ﬂuorescence spectrometer, this value was de-
termined to be a ¼ 0.017. Because a depends on the excitation intensities I1
and I2, this value is highly device speciﬁc andmust be obtained separately for
every setup. For the microscope setup used in our experiments, a was
measured to be a ¼ 0.27. It is important to note that the images from mi-
croscopic measurement were corrected for inhomogeneous illumination.
Due to the spectral overlap in the eCFP and eYFP emission, the eYFP
emission ﬁlter did not block the bathochromic part of the eCFP emission
(Fig. 1). Therefore, the FRET image was corrected for contribution of the
eCFP emission in the eYFP channel. The eCFP bleedthrough, b ¼
FDexlD ;emlA
=FDexlD ;emlD
, was obtained by measuring cells expressing only
eCFP. The ratio of the eCFP emission obtained from the FRET image and the
donor image was of about b¼ 1.20 for the used ﬁlter sets of our microscope
setup. The eCFP bleedthrough is not an issue (compare Eqs. 8 and 11) in the
ﬂuorescence spectrometer calibration experiments, because the unmixing
procedure separated eYFP from eCFP emission.
The same excitation wavelengths of 420 nm and 500 nm used in the
microscopic measurements were used for the calibration experiments at the
ﬂuorescence spectrometer to keep measurements comparable.
Data analysis
The FRET signal
In donor/acceptor FRET experiments, the detected ﬂuorescence signal F(l)
can be interpreted as a superposition of donor and acceptor emission quan-
tities
FðlÞ ¼ FDðlÞ1FAðlÞ; (1)
where FDðlÞ and FAðlÞ are the ﬂuorescence signal with the characteristic of
the donor or acceptor spectra. The contribution of the donor signal in FDðlÞ
contains two components: I is the signal from free donors (D), and II is the
unquenched ﬂuorescence from donors within FRET complexes (DA). The
contribution of the acceptor signal FAðlÞ typically contains three parts
(17,18) originating from III, the direct excitation of free acceptors (A), IV
acceptors within FRET distance, and V acceptors excited via resonant energy
transfer, often called sensitized emission.
where FiðlÞ is the ﬂuorescence signal at the excitation wavelength li; Ii is the
corresponding excitation intensity; eDðlÞ and eAðlÞ are the characteristic
emission spectra of the donor and acceptor normalized to unit area, eiD and e
i
A
are extinction coefﬁcients of donor and acceptor at the excitation wavelength
li; FD and FA are ﬂuorescence quantum yields of donor and acceptor; E is
the characteristic FRET efﬁciency of the donor acceptor complex; and the
function h(l) is the wavelength-dependent detection efﬁciency of the in-
strument used.
ðIÞ ðIIÞ
FiðlÞ ¼ IihðlÞ  eDðlÞðe
i
DFD½D1 eiDFD½DAð1 EÞÞ
1 eAðlÞðeiAFA½A1 eiAFA½DA1 eiDFA½DAEÞ
 !
;
ðIIIÞ ðIVÞ ðVÞ
(2)
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Fluorescence spectrometer measurements
Using a ﬂuorescence spectrometer, the fractions of donor and acceptor
emission signals can be deduced by ﬁtting the linear combination of donor
and acceptor reference spectra to the detected emission characteristic
F
iðlÞ ¼ ½CiFrefD ðlÞ1 ½Y iFrefA ðlÞ; (3)
where ½Ci and ½Yi are the apparent concentrations of the donor and acceptor
in the signal, and FrefD ðlÞ ¼ IreferefD FDhðlÞeDðlÞ½Dref  and FrefA ðlÞ ¼
IreferefA FAhðlÞeAðlÞ Aref
 
are the reference spectra, which must be obtained
in a separate reference measurement of cells containing only donor and
acceptor at the concentrations ½Dref  and ½Aref ; respectively.
The apparent concentrations can then be derived from Eqs. 2 and 3 as
½Ci ¼ I
ieiD
I
referefD
ð½D1 ð1 EÞ½DAÞ
½Dref 
½Y i ¼ I
ieiA
I
referefA
ð½A1 ð11EeiD=eiA½DAÞÞ
½Aref  : (4)
The fractions of donor and acceptor in FRET complex is deﬁned as
fD ¼ ½DA½D1 ½DA ¼
½DA
½Dt ;
fA ¼ ½DA½A1 ½DA ¼
½DA
½At ; (5)
where fD and fA are the fractions and [D
t] and [At] are the total concentration
of donor and acceptor, respectively, participating in complexes. Thus Eq. 4
can be rewritten as
½Ci ¼ I
ieiD
I
referefD
ð1 EfDÞ ½D
t
½Dref 
½Y i ¼ I
ieiA
I
referefA
11
eiD
eiA
EfA
  ½At
½Aref : (6)
In the deﬁned situation of a one to one FRET construct like EPAC* with
equal total donor and acceptor concentrations ½Dt ¼ ½At
fD ¼ fA :¼ fDA: (7)
EPAC* calibration
The cAMP dependence of EPAC* can be calibrated by the sensitized
emission FRET signal using a ﬂuorescence spectrometer. To achieve a cal-
ibration function that is independent from the EPAC* concentration, the
apparent acceptor concentration ½Yi must be obtained at two excitation
wavelengths: at donor excitation wavelength l1, where mostly the donor is
excited, and at the acceptor excitation wavelength l2, where the donor must
not be excited (19). Fitting both EPAC* ﬂuorescence signals FiEPACðlÞ ¼
½CiFrefD ðlÞ1½YiFrefA ðlÞ with the reference spectra obtained at one excitation
wavelength using Eq. 6, the ratio of ½Yi can be rewritten as
e1D
e1A
EfDA ¼ ½Y
1  a½Y2
a½Y2 ; (8)
where a ¼ I1e1A=I2e2A is the relative acceptor emission intensity for the two
used excitations, which must be obtained in a separate experiment using
an ‘‘acceptor only’’ sample. The fractions of acceptor emission ½Yi were
obtained by unmixing the EPAC* signal (Fig. 2) with the reference emission
spectra of eCFP FrefD ðlÞ and eYFP FrefA ðlÞ for both excitation wavelengths li,
according to FiEPACðlÞ ¼ ½CiFrefD ðlÞ1½YiFrefA ðlÞ: Note that to obtain ½Y1
and ½Y2; the spectra F1EPACðlÞ and F2EPACðlÞ are ﬁtted by the same reference
spectra FrefD ðlÞ and FrefA ðlÞ:
This determination of the apparent FRET efﬁciency, which was used to
calibrate the cAMP-dependent EPAC* FRET signal, is similar to the one
presented in Lakowicz (20), Hoppe et al. (19), and van Rheenen et al. (21).
However, in contrast to the general FRET analysis, we do not need to de-
termine the relative donor/acceptor extinction, which is labeled as e1A=e
1
D ¼ g
in Hoppe et al. (19) and is difﬁcult to obtain (22,23). A universally valid
derivation of the intensity-based FRET analysis can be found in Wlodarczyk
et al. (18) from which Eq. 8 can be derived with the constraint that the donor
must not be excited at the acceptor excitation wavelength l2.
The equilibrium of the cAMP-binding reaction to the binding sites of the
enzyme EPAC* can be expressed by a Hill equation. fDA; which is the
fraction of EPAC* in bound state (Eqs. 5 and 7), describes the equilibrium of
the cAMP-binding reaction. The cAMP dependency of EfDA=g as a function
of the Hill equation is
EfDA=g ¼ f ð½cAMPÞ
¼ ðpmax  p0Þ ½cAMP
nH
ðEC50ÞnH 1 ½cAMPnH 1 p0; (9)
where nH is the Hill coefﬁcient indicating the amount of cAMP-binding
places, p0 and pmax are offset and maximum amplitude parameters, respec-
tively, andEC50 is the cAMP concentrationwhen 50% of the cAMP-binding
sites are occupied. The cAMP concentration can then be obtained by the
reverse function
½cAMP ¼ EC50 pmax  p0ðEfDA=gÞ  p0  1
  1nH
; (10)
where EfDA=g is obtained from the sensitized emission FRET experiment
using Eq. 8.
Microscope measurements
In the microscopic analysis, the spectral information is obtained with bandpass
ﬁlters. The experimental microscopic imageswere corrected for the background
FIGURE 2 The measured EPAC* emission spectrum (420 nm excitation)
was ﬁtted by a linear combination of reference spectra for eYFP, eCFP,
Raman, and background. The reference spectra were obtained separately.
Additionally, the residual of the ﬁtted EPAC* spectrum is shown.
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and for the inhomogeneous illumination according to the speciﬁc excitation
wavelengths. The background image was acquired under identical settings as in
the FRET experiments without applying excitation light. The inhomogeneous
illumination was recorded by ﬂuorescent slides (Chroma Technology,
Rockingham, VT). The correction for inhomogeneous illumination was es-
sential, because the intensity at the peripheral regions of the images dropped to
;80%. The intensity drop showed an individual characteristic for the used
excitation wavelengths and the speciﬁc emission channels. Slight pixel shifts
between the donor and acceptor emission channel caused by imperfect align-
ment of theDualViewwere correctedwith the help of a reference grid structure.
The three corrected images FEPACexlD;emlD
of donor excitation and donor
emission channel (donor image), FEPACexlD;emlA
donor excitation and acceptor
emission channel (FRET image), FEPACexlD;emlA
acceptor excitation and acceptor
emission channel (acceptor image) were then used for the pixel-based rela-
tive apparent FRET efﬁciency calculation. In contrast to the ﬂuorescence
spectrometer measurement, the FRET signal must also be corrected for the
emission signal of the donor in the acceptor emission channel. In the liter-
ature it is often denoted as ‘‘bleedthrough’’ or ‘‘cross talk’’ (24–26).
Thus Eq. 8 must be extended as
EfDA=g ¼
F
EPAC
ex
l
D;em
l
A
 aFEPACex
l
A;em
l
A
 bFEPACex
l
D;em
l
D
aF
EPAC
ex
l
A;em
l
A
0
@
1
A; (11)
where the relative acceptor ﬂuorescence signal a ¼ FAexlD;emlA =F
A
exlA;emlA
and
the donor bleedthrough fraction b ¼ FAexlA;emlA =F
A
exlD;emlA
were obtained in
acceptor and donor only measurements, respectively. Using the calibration
measurement obtained by the ﬂuorescence spectrometer, similar excitation
conditions must be chosen due to the g value. The pixel-based cAMP con-
centration was calculated by the inverse Hill equation (Eq. 10).
The calculated [cAMP] map was displayed in a two-dimensional RGB
(red, green, blue color model) space with color coding of the concentration,
whereas the accuracy of the [cAMP], calculated from the error of the three
corrected images (see Appendix), was used for the brightness in the [cAMP]
map. Thus thresholding the corrected images was not required.
All calculations were performed with MATLAB (MathWorks, Natick,
MA) and the DIPimage Toolbox (image processing toolbox for Matlab, Delft
University of Technology, The Netherlands). An error analysis is derived in
the appendix.
RESULTS
cAMP dependence of EPAC*
The calibration of the EPAC* sensor was performed in ly-
sates of EPAC*-transfected N1E-115 neuroblastoma cells
under the same experimental conditions as the measurements
for eCFP and eYFP references, which were used as references.
Expectedly, there was no change in the reference spectra
during changes of the cAMP concentration. The eCFP and
eYFP reference spectra (Fig. 1) were used to unmix the
[cAMP]-dependent spectra of EPAC* into linear fractions ½Ci
and ½Yi according to Eq. 3 (Fig. 2). Additionally, the cell
background and the Raman peak of the excitation were taken
into account during the linear unmixing procedure.
To calibrate theEPAC*using its FRETsignal as a functionof
cAMP concentration, we exposed cell lysates from EPAC*-
transfected cells to [cAMP] ranging from 0 M to 10 mM. As
illustrated in Fig. 3 A, the background-corrected spectra of
EPAC* revealed the characteristic FRET behavior. Moreover,
the emission range of eCFP showed a higher intensity upon
increase in [cAMP],whereas the intensity of the emission range
of eYFP decreased. The contributions of the reference spectra
are shown in Fig. 3B. Thus, the emission of eCFP increased and
the emission of eYFP decreased during a rise of [cAMP] as
described byPonsioen et al. (10). The reduced donor quenching
induced an increased eCFP emission signal, whereas a reduced
sensitized emission signal was responsible for the decrease in
the eYFP emission signal. The [cAMP]-dependent changes in
the spectra are illustrated by arrows in Fig. 3 B.
At the excitation wavelength l1 (420 nm) the eYFP is
barely excited, resulting in a strong contribution (up to 40%)
of the change in the eYFP to the EPAC* signal, whereas the
change in the eCFP contribution was relatively low (;15 %).
Assuming that all EPAC* molecules are in the FRET state at
low [cAMP] and in the non-FRET state at high [cAMP], the
change in characteristic FRET efﬁciency E was calculated to
be DE ¼ 0.15 6 0.01 (Eq. 2).
Calibration of EPAC*
Using the data from the unmixing calculations (Fig. 3 B), the
ratios between the donor ½C420 nm and acceptor concentra-
tions ½Y420 nm in the EPAC* emission signal (Eq. 3) were
analyzed by varying [cAMP]. The eYFP/eCFP ratio is often
FIGURE 3 (A) [cAMP]-dependent EPAC* emission spectrum. Spectra
were obtained from a diluted supernatant of homogenized and centrifuged
N1E-115 cells transfected with EPAC*. cAMP was directly applied into the
supernatant solution. (B) EPAC* emission spectra were unmixed into linear
fractions of eCFP and eYFP reference spectra. Curve shapes of these
reference spectra were obtained by separate measurements (Fig. 1). The gray
arrows indicate the intensity change with increasing [cAMP]. All presented
spectra are corrected for background and autoﬂuorescence.
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taken as a relative value for the apparent FRET efﬁciency
(e.g., Ponsioen et al. (10)). In Fig. 4 A this ratio is plotted
versus [cAMP] for two characteristic calibration measure-
ments. The curves were ﬁtted by the Hill equation (Eq. 9).
Even though the curve shapes were similar within different
experiments, indicating EC50 ¼ ð1:6 6 0:08ÞmM and nH ¼
0:99 6 0:05; there was a clear offset between the curves.
The offsets were attributed to different cell batches, indi-
cating that, most likely during cell cultivation, an irreversible
intensity change mainly of eYFP appeared; whereas its
characteristic emission spectrum remained unchanged. Such
intensity changes made it impossible to use the eYFP/eCFP
ratio for a direct cAMP calibration of EPAC*. To clarify
whether it is possible to refer to the EfDA=g instead of the
eYFP/eCFP ratio as a parameter for the calculation of cAMP
concentration, we proved the independence of the EfDA=g
value from non-FRET related intensity changes in eYFP
emission. For that, ﬂuorescence spectra of EPAC* were
taken at different pH conditions. Asmentioned before, the pH
value is known to interfere with the ﬂuorescence properties of
eYFP (1). Indeed, we observed pH-dependent changes in the
intensity of the unmixed eYFP ﬂuorescence signal (which,
however, did not inﬂuence the characteristic emission spec-
trum eAðlÞ). The ﬂuorescence signal obtained for eCFP re-
mained unchanged at a pH varying between 6.5 and 8.
The variations in eYFP intensity obtained in the above ex-
periments resulted in a strong pH dependence of the eYFP/eCFP
intensity ratio in the case ofEPAC* (Fig. 4C).ApHdependence,
however, was not found for the EfDA=g value (Fig. 4D), which
conﬁrms that this value is independent from the non-FRET re-
lated variations in eYFP intensity. In Fig. 4B,EfDA=g values are
plotted as a function of the [cAMP]. By ﬁtting this correlation
with the Hill equation, there were no signiﬁcant offset shifts be-
tween the ðEfDA=gÞð½cAMPÞ curves, indicating EC50 ¼
ð1:5 6 0:2ÞmM and nH ¼ 0:95 6 0:05: The comparison of
Fig. 4, A and B, also shows that anEfDA=g calibration curve can
be applied to different experiments performed under similar
conditions, whereas the calibration curves based on eYFP/eCFP
intensity ratios were strongly dependent on the particular exper-
iment. In addition, the Hill coefﬁcient nH of about1 (Fig. 4 B)
corresponds with the assumption of a single cAMP-binding site
described for Epac1 (4) and consequently for EPAC*.
From the amplitudes of the ﬁtted Hill equation, which was
6.5 6 0.1 at low and 3.75 6 0.1 at high [cAMP], the char-
acteristic FRET efﬁciency was estimated to be 35% 6 2%
and 20% 6 2%, respectively.
Spatially and time-resolved quantitative
[cAMP] measurements
To analyze the spatial and temporal changes of [cAMP] in
living cells, microscopic measurements were performed on
N1E-115 neuroblastoma cells cotransfected with plasmids
encoding for EPAC* and for 5-HT7 receptors. The 5-HT7
FIGURE 4 [cAMP]-calibration curves for EPAC*. (A) eYFP/eCFP ratio (½a420nm=½d420nm from Eq. 3) for [cAMP] calibration of EPAC* with (o) and
without (x) autoﬂuorescence correction. Data were obtained from two representive experiments (red and blue) with different cell batches that were similarly
treated. The data are ﬁtted using the Hill equation (Eq. 9). Resulting parameters are shown in the graph. (B) The relative apparent FRET efﬁciency EfDA=g (Eq.
8) of the same data as in A is used for [cAMP] calibration. (C) pH dependence of the eYFP/eCFP ratio of the EPAC* emission signal is ﬁtted with the Hill
equation. (D) The pH dependency of EfDA=g shows a constant behavior.
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receptor is coupled to the stimulatory Gs-protein, and receptor
stimulation with agonist results in the increase of the intracel-
lular cAMP concentration (27,28). Receptor-mediated changes
of the cAMP level were induced by bath application of the
5-HT7 receptor agonist, 5-CT (1mM),which has a high afﬁnity
for 5-HT7 receptors (29). The bath was exchanged within 30 s,
raising the local [5-CT] up to 90% of its maximumwithin 10 s.
The ﬂuorescence was monitored over three periods of 117 s,
corresponding to before, during, and after 5-CT application.
5-CT induced changes of [cAMP] were calculated quanti-
tatively based on the changes in the apparent FRET efﬁciency
(Fig. 5). The statistical analysis of 11 cotransfected cells showed
that the receptor-mediated increase of [cAMP] ranged from a
basal level of 0.32 6 0.62 mM to reach a maximal concentra-
tion of 1.62 6 1.83 mM upon 5-CT application. The large
standard errors of means reﬂect major regional differences. This
was also veriﬁed by examining speciﬁc subcellular regions
of interest (Fig. 5, A–F; see also Supplementary Material,
Movie S1 and Movie S2 for the whole time range). The basal
[cAMP] was dispersed inhomogeneously, indicating the exis-
tence of microdomains with constitutive [cAMP] production.
The lowest basal concentration was 0.16 0.1 mM, which is at
the lower resolution limit of EPAC*. Within the patchy micro-
domains, however, the basal [cAMP] ranged;0.4 6 0.3 mM.
Such preexisting microdomains with elevated basal [cAMP]
showed a more pronounced response to the 5-CT application
(‘‘active’’ microdomains) (Fig. 5, B and E), and there the
[cAMP] quickly increased up to 9 mM, whereas the increase
of [cAMP] in surrounding ‘‘passive’’ regions remained below
2 mM.
The [cAMP] changes started at the plasmamembrane, where
it reached its highest levels and propagated in the form of a
cAMP wave with a speed of ;0.2 mm/s into the cytosol
(Movie S2). It is noteworthy that [cAMP] did not increase
synchronously within the various microdomains, and rather
differently changed within individual microdomains that sub-
sequently spilled over into neighboring microdomains (Fig. 5,
D–F). These ﬂuctuations in the spatial distribution of [cAMP]
resulted in the highly dynamic movie. Although signals are
seen in the area of the nucleus, the cell nucleus itself did not
FIGURE 5 cAMP increase as a response to agonist activation of 5-HT7 receptor. (A, B, D, and E) [cAMP] map of two N1E-115 cells, which had been
transfected with EPAC* and 5-HT7 receptor at basal level (A andD) and during stimulation (B and E) to 1 mM 5-CT. Quantitative [cAMP] are color coded in a
range from 0 to 4.5 mM and 0 to 10 mM, respectively. The average [cAMP] time courses from selected microdomains (circles in concentration map) are shown
in C and F. The region colors correspond to the line colors in C and F. The dotted line in white encircles the region of the nucleus.
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reveal any cAMP signals since EPAC* is expressed only in the
cytosol. It is also notable that the agonist-mediated increase of
the cAMP concentration was 5-HT7 receptor speciﬁc, because
the agonist-mediated increase of cAMP concentration was
completely blocked by parallel application of the receptor-
speciﬁc antagonist SB269970 (data not shown).
DISCUSSION
The FRET technology becomes increasingly important for
studying protein-protein interactions in various biological
samples. For a quantitative analysis of intensity-based FRET
measurements, however, a set of additional calibration mea-
surements is required that includes ﬂuorescence lifetime
measurements performed under deﬁned conditions. To over-
come such extensive calibration steps, FRET-based biosensors
with a ﬁxed donor/acceptor stoichiometry of 1:1 have been
designed that utilize the acceptor/donor ﬂuorescence intensity
ratio as a measure of the FRET signal. However, the ﬂuores-
cence intensity ratio is often insufﬁcient for calibrating and
quantitative analysis because it depends on secondary, envi-
ronmental factors, including pH and anion concentration (1).
In this study, we describe, to our knowledge, a novel
method for the quantitative FRET analysis, which can be ap-
plied to the biosensor with a ﬁxed donor/acceptor stoichiom-
etry. The FRET-based cAMP biosensor EPAC* (10) was used
as a model, The general spectroscopic properties of EPAC* as
well as calibration experiments were achieved by ﬂuorescence
spectrometry allowing 1), a precise analysis of the spectral
changes in the signal; 2), a higher sensitivity and accuracy due
to a larger signal; and 3), averaging ﬂuorescence signals from
numerous cells simultaneously. We found that the spectrum of
EPAC* can be ﬁtted by superposition of the reference spectra
of eCFP and eYFP (Fig. 3 B). EPAC* activation by cAMP
increased the ﬂuorescence intensity of eCFP, whereas the
ﬂuorescence intensity of eYFP decreased, as was expected
according to a decrease in the FRET signal. The proﬁle of the
ﬂuorescence spectra of eCFP and eYFP remained unchanged
even when cAMP concentrations varied. It is notable that the
calibration curves obtained by using the eYFP/eCFP intensity
ratio plotted against cAMP concentration varied between dif-
ferent cell batches (Fig. 2 A). However, only variations in the
ratio (po and pmax  vertical shift)—but neither in the EC50
values of 1.6 6 0.1 mM nor in the Hill coefﬁcient of nH ¼
1 6 0.5—were observed. Variations in the cAMP concen-
tration before lysing cells cannot explain such behavior.
It has been reported that the ﬂuorescence intensity of the
eYFP depends on the pH and other anion concentrations (1),
whereas the proﬁle of its ﬂuorescence spectra remains un-
changed. To evaluate the role of pH for the obtained varia-
tions in the eYFP/eCFP ratio, we measured emission spectra
of eCFP and eYFP upon different pH conditions. The in-
tensity of eCFP remained stable (64%) as the pH ranged
from 6.5 to 8, whereas the eYFP intensity was dramatically
quenched (compare Fig. 2 C). Therefore differences in the
eYFP/eCFP intensity ratio obtained for EPAC* seem to
originate from pH-dependent changes in the intensity of
eYFP rather than of eCFP. Consequently, the eYFP/eCFP
ratio cannot be used as a direct quantitative measure of the
cAMP concentration. To overcome this limitation, we de-
veloped a simpliﬁed FRET-based analysis method. This
method is based on two-wavelength excitation in which the
sensitized emission signal is scaled by the eYFP intensity,
resulting in the EfDA=g value (Eq. 9). The exposure of the cell
lysates containing EPAC* to different pH values revealed
that the value EfDA=g does not signiﬁcantly change at dif-
ferent pH values (Fig. 4 D), whereas the eYFP/eCFP ratio
showed a signiﬁcant change with pH (Fig. 4 C). The ﬁnding
demonstrates that the EfDA=g value is independent from non-
FRET related variations of eYFP signals, whereas the eYFP
reference spectrum remains constant. The calibration of
EPAC* by using the EfDA=g value instead of the eYFP/eCFP
ratio resulted in similar curves of different cell batches. The
extreme pmax and po varied within an error of ,61%,
whereas the ratio exhibited a variation of .67%.
Fitting the EfDA=g data by the Hill equation provided ad-
ditional important information about EPAC* properties: the
Hill coefﬁcient of nH ¼ 1.05 6 0.05 is in line with the
assumption of a single binding cAMP site suggested for
Epac1 and Epac2, the EC50 value for EPAC* was 1.56 0.2
mM, which is in disagreement with that obtained by Ponsioen
et al. (10), who proposed an EC50 value of 14 mM. Two
things may lead to such a discrepancy. First, we observed
signiﬁcant degradation of cAMP in a frozen stock solution
after a few weeks by a shift of the EC50 value. Thus we use
only a solution of freshly dissolved cAMP for our experi-
ments. Second, we could prove in our study here that the
ratiometric analysis could be afﬂicted with an error of non-
FRET related intensity changes of the acceptor.
Besides the EC50 value, the characteristic FRET efﬁ-
ciency E must also be taken into account, because it affects
the signal/noise ratio. From the donor quenching (DE¼ 15%6
1%) and the cAMP concentration dependence of EfDA=g
value, a characteristic FRET efﬁciency E of EPAC* was
estimated to be 35%6 2% at low [cAMP], as E was reduced
to 20% 6 2% at high [cAMP]. In the ‘‘FRET-positive’’
conformation state of EPAC*, E was found to be only
slightly lower than the E of 37% obtained for eCFP-eYFP
tandem constructs (18). In the so-called ‘‘FRET-negative’’
state, the apparent FRET efﬁciency was reduced to ;57%
of its maximal value. Thus, the presumed conformational
changes between the EPAC molecule at cAMP bound and
nonbound states are not very pronounced in the case of
EPAC*. It is more likely that only slight changes in distance
and/or orientation of the EPAC-bound ﬂuorophores are re-
sponsible for the moderate differences in the apparent FRET
efﬁciency. The accuracy of the biosensor could be optimized
by exploiting the complete dynamic range of the eCFP-eYFP
FRET pair. For further studies, this method can also be
employed to obtain the characteristic FRET efﬁciencies of
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other cAMP biosensors working on the base of Epac1 and
Epac2.
After the FRET-based biosensor was characterized and a
calibration curve had been acquired, the optimized FRET-
based analysis method was applied to the microscopic studies
at the single-cell level. Only two intrinsic constants, a and b,
of the microscope needed to be determined. However, it was
recognized that there are additional factors that may create
signiﬁcant artifacts. Slight variations in the emission intensity
proﬁle were found for different excitation wavelengths. Thus,
besides the standard background correction, the intensity
shading (up to 20%) also has to be corrected to achieve the
required accuracy. Also, the pixel-based analysis required an
optimized beam pathway. Remaining slight pixel shifts in the
image were corrected during image processing. Shifts and
rotation of the images were more pronounced when an image
splitter was used. To diminish systematic errorswhile applying
the calibration curve obtained by the ﬂuorescence spectrom-
eter to the data frommicroscopy, we suggest obtaining at least
one characteristic point of the calibration curve (i.e., p0 for low
[cAMP] or pmax for high [cAMP]) at the microscope setup. In
contrast, the EC50 and the nH values can be taken over from
the calibration measurements and must not be redetermined in
a microscope measurement since they depend only on the
binding afﬁnity of cAMP to EPAC*.
To prove the EfDA=g-based FRET method, we performed
microscopic measurements of [cAMP] in neuroblastoma cells
coexpressing EPAC* and 5-HT7 receptor. The [cAMP] in-
crease was pronounced in all measurements but never sur-
passed the upper concentration limit of the biosensor, which is
;15 mM. The agonist-mediated [cAMP] increase was local-
ized in several subcellular microdomains. The spatial and
temporal resolved analyses of individual cells revealed
[cAMP] gradients of 0.5 mM/mm. At basal conditions, mi-
crodomains with three times higher [cAMP] coexist and are
surrounded by areas that remained inactive at low [cAMP]
(,0.3 mM). Stimulation of the 5-HT7 receptor with an ago-
nist-induced [cAMP] increased in a range of several mM
within speciﬁc microdomains. This ﬁnding corresponds to the
two-compartment model proposed byRich et al. (30) assuming
a diffusion restriction between microdomains and the cytosol.
The microdomains in neuroblastoma cells had dimensions that
are similar to the cAMP microdomains analyzed in neonatal
cardiac myocytes (31).
The high basal [cAMP] levels within distinct cell micro-
domains seem to be caused by a constitutive activity of 5-HT7
receptors (32), which are known to be clustered within mem-
brane microdomains (E. Ponimaskin, D. W. Richter, un-
published results). Moreover, an agonist-induced increase in
[cAMP] was observed mainly in these microdomains that
were endogenously active and produced spatial gradients of
up to 3 mM/mm. This suggests a higher density of 5-HT7
receptors and/or its effectors (including Gs-protein and AC)
within microdomains than within surrounding regions with
low activity. An additional reason for the existence of cAMP
microdomains may be a compartmentalization of ACs or
phosphodiesterase (6,33). During 5-HT7 receptor activation,
the [cAMP] increase started from the plasma membrane as a
wave of the cAMP signal that propagates with a speed of
;0.2 mm/s. This speed is lower than the free diffusion of
cAMP (300 mm2/s) in cytoplasm (34,35). Although we ob-
tained a diffusion constant of 6–7 mm2/s for cAMP-free
EPAC*, it cannot be excluded that the observed propagation
of the cAMP signal is masked by an EPAC* diffusion. Our
data are in line with the ﬁndings of Rich et al. (30), who
showed that the microdomains need;150 s to be ﬁlled up by
a process that is not related to unrestricted diffusion (2 ms).
We conclude that cAMP waves start at clustered receptors
and continue with directed cAMP ﬂuxes along connected
microdomains toward regions surrounding the nucleus. The
functional signiﬁcance of such directed cAMP trafﬁc needs
further clariﬁcation.
So far, we have assumed that the buffer capacity of EPAC*
is negligible, because this was not the focus of our study.
However the buffer capacity needs to be considered for fur-
ther single-cell analysis of quantitative [cAMP], which is a
principal aspect of all biosensors.
In conclusion, the presented FRET-based approach can be
applied to different FRET-based biosensors for a quantitative
analysis of [cAMP], the characteristic FRET efﬁciency, the
dynamic range, and its speciﬁcity. This approach is inde-
pendent from the ionic environment and can be applied to
microscopy at a subcellular level with a high spatial and
temporal resolution. The change in the apparent FRET efﬁ-
ciency of EPAC* caused by the conformational change is
often far from the theoretical optimum, which diminishes the
signal/noise ratio of the response and thus its sensitivity.
Such a technique for quantitative analysis of FRET-based
biosensors is also a requirement for the high throughput
screening. The prospect of (to our knowledge) the novel
FRET-based approach for quantitative measurements of
[cAMP] is to analyze signaling processes quantitatively, in-
cluding the inﬂuence of basal concentrations and the option
to verify the signiﬁcance of microdomains and their dy-
namics.
APPENDIX
Error analysis
The error of EfDA=g from Eq. 11 follows according to the exact differential
method:
y ¼ Fðx~Þ
varðyÞ ¼ +
i
@F
@xi
 2
varðxiÞ
" #
;
where var(y) is the variance of y. The standard error of EfDA=g is then
sEfDA=g ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
varðEfDA=gÞ
p
:
According to the total derivative
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var (a) and var (b) are signiﬁcantly smaller than var (F) because a and b are
obtained from large regions of interest (nROI 1) in reference measurements
with var (a); 1/nROI,a and var(b); 1/nROI,b. Thus the error of EfDA/g is
determined mainly by the terms containing varðFEPACexlD;emlA Þ; varðF
EPAC
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assuming that the error of a pixel is dominated by Poisson noise of the
background-corrected image varðFÞ;F: Thus,
Note that as a reasonable approximation, varðEfDA=gÞ; 1=I: Thus to take
the inverse of the 1-norm kIk1 of the three obtained images with
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
I111I
1
21I
1
3
p
is a reasonable approach to estimate the reliability of the measurement rather
than the two-norm kIk2 with
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
I211I
2
21I
2
3
p
: To better calculate a measure for
the accuracy, Eq. 12 can be used:
Because we used Eq. 13 only for the brightness information of our
pseudocolor images, no signiﬁcant difference was found between it and
the simpler one-norm approach.
Error estimation of [cAMP]
The error of [cAMP] can now be estimated from the total derivative of
Eq. 10.
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Assuming the parameters EC50, p0, pmax, and nH can be obtained precisely,
the equation simpliﬁes to
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The relative error for [cAMP] is than
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where ðp0  pmaxÞ=ððEfDA=g  p0ÞðEfDA=g  pmaxÞÞ represents the relative
‘‘position’’ at the slope of the calibration curve.
In contrast to the image brightness correction (Eq. 13), where only a factor
proportional to sEfDA=g was needed for the relative error of [cAMP], at least
the proportionally constant (i.e., detector gain) must be obtained. This is
usually done by the pixel intensity ﬂuctuation analysis of a homogeneous
ﬂuorescent sample. Taking into account the simpliﬁcations introduced to
receive Eq. 14, obtaining the relative error of [cAMP] directly from a
homogeneous [cAMP] region of an image or from an image sequence is
recommended.
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